Gimv launches life sciences investment platform
Listed investor Gimv is carving out its life sciences portfolio into a new platform that will give it the firepower to deploy bigger tickets and increase the size of its portfolio, the firm tells Unquote.
More on GPs
HIG Europe's lower mid-cap strategy eyes succession and carve-out opportunities
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Alderwood Capital mulls significant stake sale in bid to kickstart PE fund
London-based GP was formed in 2020 and aims to raise a fund to take minority stakes in boutique asset managers
Inflexion sells Pharmaspectra to IQVIA for USD 100m
Exit of medical data disseminator generates 25% IRR after three years of ownership
GP Profile: Tikehau’s Aerofondo set for aerospace industry take-off after first deal from debut fund
Spanish aerospace strategy aims to attract total commitments of EUR 150m-EUR 200m, with strategic LPs already in place
Latest News
Aurelius exits Transform Hospital Group to Y1 Capital
Buyer adds cosmetic surgery chain to portfolio of healthcare assets; is targeting IPO on Nordic Growth markets
HIG Europe's lower mid-cap strategy eyes succession and carve-out opportunities
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Golding Capital holds EUR 65m first close for debut impact fund
Fund-of-funds has made two investments to date and plans to attract further European institutional LPs
GRO Capital acquires majority stake in Netigate
Acquisition of the Swedish customer and employee feedback platform follows a Houlihan Lokey-led sale process